The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•13 February 2026•

1 min read

Mohawk, West Pharma, and Ambev Exceed Expectations with Strong Q4 Earnings

3D metallic 'PVH' text with 'CALVIN KLEIN' and 'TOMMY HILFIGER' names. Upward trend line, 'EARNINGS BEAT', 'REVENUE: +14%', and '2026 GUIDANCE' on an orange background.

Three major publicly traded companies—Mohawk Industries, West Pharmaceutical Services, and Ambev SA—reported fourth-quarter financial results that significantly exceeded analyst estimates. Mohawk Industries reported an earnings per share (EPS) of $2.00 on revenue of $2.7 billion, surpassing market expectations by $0.02. West Pharmaceutical Services also beat expectations with an EPS of $2.04 and issued optimistic guidance for fiscal year 2026, targeting between $7.85 and $8.20 per share. Ambev SA delivered a substantial surprise, announcing an EPS of $0.280, which far outpaced the analyst consensus of $0.051. The strong performance across these diverse sectors was driven by robust operational execution during the final quarter of the year. Positive earnings surprises and upward revisions to future guidance are expected to bolster investor confidence and drive immediate stock price appreciation.